Stocks

Envestnet Q2 2024 Results Show Growth and Upcoming Bain Acquisition

Envestnet, Inc. Reports Second Quarter 2024 Earnings Amid Transition and Growth Envestnet, Inc., a prominent provider of intelligent systems for…

Read More »

Cadre Holdings Targets Growth After Strong Q2 Performance

Cadre Holdings (ticker: CDRE) has announced strong financial results for the second quarter of 2024, showcasing significant increases in net…

Read More »

Owlet Reports Strong Q2 Growth and Plans for Global Expansion

Owlet Baby Care Inc. (OWLT), a prominent player in infant health monitoring technology, has demonstrated robust financial growth in the…

Read More »

Biora Therapeutics Reports Progress on BT-600 and BioJet Platforms

Biora Therapeutics has announced significant progress in its BT-600 program and BioJet platform during its recent earnings call. The company…

Read More »

Viant Technology Experiences Growth Amid Changing Advertising Landscape

In its recent earnings call, Viant Technology Inc. (NASDAQ: DSP) reported an impressive second quarter for 2024, showcasing a 15%…

Read More »

Aspira Women’s Health Sees Growth with OvaWatch Expansion

Aspira Women’s Health Reports Strong Q2 2024 Results, Highlights OvaWatch Growth Aspira Women’s Health, Incorporated (AWH) has announced impressive results…

Read More »

BuzzFeed Reports Q2 2024 Earnings, Emphasizes AI Growth

BuzzFeed Reports Q2 2024 Earnings with Focus on Generative AI and Interactive Content BuzzFeed, Inc. announced its earnings for the…

Read More »

Fathom Holdings Reveals New Plans Amid Q2 Revenue Decline

Fathom Holdings Inc. (FATH) Quarterly Update Fathom Holdings Inc., a national real estate brokerage, reported a decline in total revenue…

Read More »

CXAI Reports Strong Q2 2024 Results and Significant Deals

CXAI, an AI and enterprise software firm, has shared notable updates regarding its business progress and financial outcomes during the…

Read More »

Belite Bio Reports Progress in Tinlarebant Trials and Q2 Financials

Belite Bio (ticker: BLTE), a biotechnology company, has announced important progress in its clinical trials for Tinlarebant, a treatment for…

Read More »